Linezolid-associated serotonin toxicity: a systematic review.
Fawzy A ElbarbryNicholas MoshirianPublished in: European journal of clinical pharmacology (2023)
Linezolid therapy when optimal should not be deferred due to the risk of serotonin syndrome. The data collected reveals a low prevalence of serotonin toxicity in both linezolid monotherapy and linezolid concurrent with other serotonergic agents.